Steven Andrew Egleston, MD | |
1408 N Florence, Claremore, OK 74017 | |
(918) 341-1044 | |
(918) 341-7443 |
Full Name | Steven Andrew Egleston |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 24 Years |
Location | 1408 N Florence, Claremore, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508838038 | NPI | - | NPPES |
100069280A | Medicaid | OK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 22585 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Cherokee Nation W W Hastings Indian Hospital | Tahlequah, OK | Hospital |
Jane Phillips Memorial Medical Center, Inc | Bartlesville, OK | Hospital |
Claremore Indian Hospital | Claremore, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cherokee Nation | 5799698742 | 329 |
News Archive
In testimony today before the Senate Health, Education, Labor and Pensions Subcommittee on Children and Families, Elissa O'Brien, SPHR, vice president of human resources for Wingate Healthcare, urged Congress to consider alternative approaches to policies governing workplace leave that reflect the needs of today's workforce.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that data provided in a presentation entitled, "Antitumor activity of single small molecule agent targeting PI3K/mTor and HDAC," were presented at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010, which is being held in Washington, DC April 17-21.
Researchers at the University of Delaware, working with colleagues at Indiana University, have gained new insights into the virus that causes hepatitis B - a life-threatening and incurable infection that afflicts more than 250 million people worldwide.
In a medical breakthrough scientists have found that gene therapy could be used to cure leukemia. Researchers at the University of Pennsylvania engineered patients' own pathogen-fighting T-cells to target a molecule found on the surface of leukemia cells. These genetically modified T-cells were grown outside of the body and infused back into patients suffering from late-stage chronic lymphocytic leukemia (CLL), which affects the blood and bone marrow and is the most common form of leukemia.
Novel smartphone and tablet applications for atrial fibrillation patients and healthcare professionals have been launched by heart experts. The objectives and design of the apps are outlined in a paper published online today in EP Europace, with a summary published in the European Heart Journal.
› Verified 4 days ago
Entity Name | Cherokee Nation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780692723 PECOS PAC ID: 5799698742 Enrollment ID: O20031106000628 |
News Archive
In testimony today before the Senate Health, Education, Labor and Pensions Subcommittee on Children and Families, Elissa O'Brien, SPHR, vice president of human resources for Wingate Healthcare, urged Congress to consider alternative approaches to policies governing workplace leave that reflect the needs of today's workforce.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that data provided in a presentation entitled, "Antitumor activity of single small molecule agent targeting PI3K/mTor and HDAC," were presented at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010, which is being held in Washington, DC April 17-21.
Researchers at the University of Delaware, working with colleagues at Indiana University, have gained new insights into the virus that causes hepatitis B - a life-threatening and incurable infection that afflicts more than 250 million people worldwide.
In a medical breakthrough scientists have found that gene therapy could be used to cure leukemia. Researchers at the University of Pennsylvania engineered patients' own pathogen-fighting T-cells to target a molecule found on the surface of leukemia cells. These genetically modified T-cells were grown outside of the body and infused back into patients suffering from late-stage chronic lymphocytic leukemia (CLL), which affects the blood and bone marrow and is the most common form of leukemia.
Novel smartphone and tablet applications for atrial fibrillation patients and healthcare professionals have been launched by heart experts. The objectives and design of the apps are outlined in a paper published online today in EP Europace, with a summary published in the European Heart Journal.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Steven Andrew Egleston, MD 1408 N Florence, Claremore, OK 74017 Ph: (918) 343-2393 | Steven Andrew Egleston, MD 1408 N Florence, Claremore, OK 74017 Ph: (918) 341-1044 |
News Archive
In testimony today before the Senate Health, Education, Labor and Pensions Subcommittee on Children and Families, Elissa O'Brien, SPHR, vice president of human resources for Wingate Healthcare, urged Congress to consider alternative approaches to policies governing workplace leave that reflect the needs of today's workforce.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that data provided in a presentation entitled, "Antitumor activity of single small molecule agent targeting PI3K/mTor and HDAC," were presented at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010, which is being held in Washington, DC April 17-21.
Researchers at the University of Delaware, working with colleagues at Indiana University, have gained new insights into the virus that causes hepatitis B - a life-threatening and incurable infection that afflicts more than 250 million people worldwide.
In a medical breakthrough scientists have found that gene therapy could be used to cure leukemia. Researchers at the University of Pennsylvania engineered patients' own pathogen-fighting T-cells to target a molecule found on the surface of leukemia cells. These genetically modified T-cells were grown outside of the body and infused back into patients suffering from late-stage chronic lymphocytic leukemia (CLL), which affects the blood and bone marrow and is the most common form of leukemia.
Novel smartphone and tablet applications for atrial fibrillation patients and healthcare professionals have been launched by heart experts. The objectives and design of the apps are outlined in a paper published online today in EP Europace, with a summary published in the European Heart Journal.
› Verified 4 days ago
Rachel Kersker, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1408 N Florence Ave, Claremore, OK 74017 Phone: 918-341-1044 | |
Dr. Jeffrey Michael Williams, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 N Florence, 101, Claremore, OK 74017 Phone: 918-342-3633 Fax: 918-342-8959 | |
Dr. Cheri A Peterson, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 S Moore Ave, Claremore, OK 74017 Phone: 918-342-6200 Fax: 918-342-6409 | |
Dwight Julius Korgan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1408 N Florence, Claremore, OK 74017 Phone: 918-341-1044 Fax: 918-341-7443 | |
Jeannette Ramos Ramos-fast, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 South Moore Ave, Claremore, OK 74017 Phone: 918-342-6200 Fax: 918-342-6598 | |
Dr. Rebecca Ann Raelson-skonicki, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 S Moore Ave, Claremore, OK 74017 Phone: 918-342-6200 Fax: 918-342-6598 | |
Michael Cooper, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3100 Medical Pkwy, 100, Claremore, OK 74017 Phone: 918-341-1000 Fax: 918-293-3141 |